Pfizer Inc
NYSE: PFE
$29.30
-$0.12 (-0.4%)
Closing Price on September 23, 2024
PFE Articles
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all could help cushion a portfolio...
Published:
thinkstockJuly 7, 2015: Markets opened slightly higher on Tuesday but a reversal took just moments to set in and U.S. equities traded mostly lower for the remainder of the day. Commodities of all...
Published:
Last Updated:
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
Published:
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Published:
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Published:
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
Published:
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
Published:
Investors looking to move down in volatility but stay fully invested may want to consider moving capital to any of these three value stocks.
Published:
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
Published:
With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair...
Published:
thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end of the day. Both the dollar and crude oil weakened today while 10-year Treasury note...
Published:
Last Updated:
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Published:
The five most shorted stocks trading on the New York Stock Exchange remained the same between the April 15 and April 30 settlement dates.
Published:
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Published:
thinkstockMay 6, 2015: Markets opened higher on Wednesday but soon sank as growth expectations for the U.S. economy dimmed again. Fed Chairwoman Janet Yellen may have spooked investors by talking...
Published:
Last Updated: